You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

September 15, 2022

Thailand’s New Legal Framework for Kratom

Subscribe to Updates

In 2021, Thailand passed the updated Narcotics Act (No. 8) B.E. 2564 (2021), which removed kratom (Mitragyna speciosa) from the list of prohibited substances, eliminated kratom-related offenses on the basis that its consumption is part of traditional Thai cultural norms, and allowed possession and consumption.

On August 26, 2022, Thailand published the Kratom Plant Act B.E. 2565 (2022) in the Government Gazette, and the law came into effect the following day. With the aim of encouraging economic activity related to kratom, the act regulates the trade, sale, consumption, study, and advertising of kratom leaves (alone or as an ingredient in food) in Thailand.

Importing and Exporting Kratom Leaves

Importing and exporting kratom leaves without obtaining a license from the secretary-general of the Narcotics Control Board (NCB) is prohibited under the Kratom Plant Act. Eligible license recipients include:

  • Thai nationals over twenty years old and residing in Thailand;
  • Juristic persons registered under Thai law;
  • Community enterprises under the law; and
  • Government agencies.

A license is valid for five years, and importers and exporters must still notify the NCB when importing or exporting kratom leaves. An exception to the licensing requirement is bringing kratom leaves in and out of Thailand for personal consumption, therapy, and treatment of an illness. The amounts allowed for international travel are to be specified in ministerial regulations. If the amount of the kratom leaves exceeds this allowance, the transport will be considered importing or exporting of kratom leaves, triggering the licensing requirements described above.

Violation of these requirements is subject to imprisonment for up to one year, a maximum fine of THB 100,000, or both.

Selling Kratom

The Kratom Plant Act also allows the sale of kratom leaves alone or as an ingredient in food, subject to certain conditions. Under the law, sales of kratom include selling, dispensing, distributing, exchanging, or giving the substance to others. The laws measures pertaining to this are intended to protect people from the potential harm of consuming or misusing kratom.

It is prohibited to sell kratom leaves or food that contains kratom leaves as an ingredient to persons under 18 years old, and pregnant or breastfeeding women. The law also authorizes ministers of the Ministry of Justice and the Ministry of Public Health to prohibit selling kratom to additional persons. Sellers must post an announcement at their place of sale (including electronic points of sale) noting the prohibition on selling kratom to these parties. Violating one of these prohibitions or not posting the required announcement or notice is punishable by a fine of up to THB 30,000.

There are two exceptions. Selling to the restricted persons mentioned above may be allowed only if done for medical or educational purposes, defined specifically as follows:

  • Treatment of disease, therapy, or relief of illness under the supervision of a medical practitioner, dental practitioner, Thai traditional medicine practitioner, or traditional medical professional under the law related to the Thai traditional medical profession; or
  • Study, analysis, or research carried out by a government agency that is responsible for conducting medical, pharmaceutical, or scientific research or education, or providing medical, pharmaceutical, or scientific services for the benefit of medical or pharmaceutical, Thai Red Cross Society, or educational institutions.

Besides the prohibitions on selling to certain parties, some locations and points of sale are also off limits for selling kratom leaves or food containing kratom leaves. Kratom leaves by themselves may not be sold in educational institutions, dormitories, parks, zoos, amusement parks, vending machines, or other places specified in announcements by ministers of the Ministry of Justice and the Ministry of Public Health. Violations are subject to a fine of up to THB 50,000—and up to twice that (i.e., THB 100,000) if the sale is to one of the prohibited parties mentioned above.

While consumption of kratom is now legal following its removal from the narcotics list, it is prohibited to consume kratom leaves mixed with narcotic drugs, psychotropic substances, dangerous substances, or any other substance specified by the Ministry of Justice, except when done for the specific medical or education purposes given above. Violation is subject to a maximum fine of THB 50,000.

Advertising

Advertising or promoting the consumption of kratom leaves mixed with narcotics or psychotropic substances, drugs and dangerous substances, or other designated substances is also prohibited under the Kratom Plant Act. This is a comprehensive ban on inducing people to consume any of these kratom-containing mixtures, covering advertisement or any type of marketing communication by means of public relations, news, publishing promotion, point-of-sale displays, direct marketing, sales, and online or computer advertising. Violations of this ban are subject to imprisonment for up to two years, a maximum fine of THB 200,000, or both.

Similarly, convincing others (including “encouraging, deceiving, intimidating, improperly influencing, or forcing”) to consume kratom leaves mixed with narcotic drugs, psychotropic substances, dangerous substances, or other designated substances is also prohibited. Violations of this prohibition are subject to imprisonment for up to one year, a maximum fine of THB 100,000, or both. Penalties can be doubled if the violation is committed against persons under age 18, pregnant or breastfeeding women, or any other person designated by the Ministry of Justice or the Ministry of Public Health, for a maximum sentence of imprisonment for two years and a fine of THB 200,000.

Conclusion

Overall, the Kratom Plant Act lays out a general framework that regulates importing and exporting kratom leaves and supervises the sale, consumption, advertising, and misuse of kratom leaves and food containing kratom leaves. However, there are still additional specific restrictions in various regulations or announcements from the NCB, Ministry of Justice, Ministry of Public Health, and other relevant agencies.

Furthermore, using kratom leaves in certain products can trigger other regulations. For example, using kratom leaves as raw materials or components of herbal products, drugs, and cosmetics may be subject to specific laws such as the Herbal Product Act, Drugs Act, or Cosmetics Act. The relevant provisions under the specific legislation will still apply—even though their restrictions and requirements could differ from those in the Kratom Plant Act.

Consequently, it is advised to seek local expert counsel before starting any business involving kratom, as it is still subject to numerous restrictions and requirements.

Related Professionals

Practices

Regulatory Affairs

Location

RELATED INSIGHTS​ 

August 10, 2026
On June 17, 2026, Indonesia’s National Agency of Drug and Food Control (BPOM) issued BPOM Regulation No. 10 of 2026 on Nutritional Information on Processed Food Labels. The new regulation, which revokes three previous nutrition labeling regulations, introduces several notable changes affecting food and beverage manufacturers, importers, and distributors. These changes range from updated nutrient reference values and serving-size requirements to the introduction of the Nutri-Level front-of-pack labeling system for certain beverage products. Businesses operating in Indonesia should carefully review these developments and assess their products’ compliance with the new requirements during the transition period. Implementation of the Nutri-Level Labeling System To implement the recently issued decree on Nutri-Level labeling, BPOM Regulation No. 10 of 2026 stipulates the requirements to implement the Nutri-Level labeling system on the front-of-pack. Under the new framework, ready-to-drink beverages, powdered beverages, and liquid or solid concentrates are required to display Nutri-Level labeling on the front label of their packaging. The Nutri-Level labeling system classifies products into color-coded levels A through D based on their sugar, sodium, and total fat content. The applicable Nutri-Level is determined based on the lowest level measured in the assessment of sugar, sodium, and total fat content. For products classified as level C or D, the Nutri-Level label must be accompanied by information on the relevant sugar, sodium, and total fat content per 100 ml of the ready-to-consume product. Products classified as level A or B may either display only the Nutri-Level designation or display the Nutri-Level together with the relevant nutritional information per 100 ml. Minimum Vitamin and Mineral Content Required for Declaration BPOM Regulation No. 10 of 2026 introduces a stricter threshold for the declaration of vitamins and minerals in the nutritional value information section (ING). Vitamins or minerals may only be declared if they are present at a
Read More
August 10, 2026
The drug registration process in Vietnam will be simplified, particularly for foreign applicants, following the recent issuance by Vietnam’s Ministry of Health (MOH) of a new circular that is expected to reduce administrative hurdles. Circular No. 32/2026/TT-BYT on the registration of drugs and medicinal ingredients (Circular 32) was issued on July 29, 2026, and will take effect on October 1, 2026, replacing Circular No. 12/2025/TT-BYT. Key provisions of the new circular are discussed below. Five-Year Data Exclusivity and Five-Month Public Disclosure Framework Circular 32 updates data protection guidelines by explicitly referencing Article 128 of the amended Intellectual Property Law, which sets out that new drugs supported by clinical trial data submitted for the first time will be granted a five-year data exclusivity period from the date of the initial marketing authorization (MA) approval. Subsequent applications that rely on the originator’s protected data will not be eligible for approval from the date of submission of the originator’s registration dossier until five years after the first MA is granted. Furthermore, in accordance with the new regulations, the regulatory authority must publicly disclose information on subsequent applications five months before the granting of MA, providing originator companies with an opportunity to exercise and enforce their intellectual property rights. Simplified Requirements for Foreign Legal Documents Circular 32 expands the circumstances under which legal documents issued by foreign authorities are exempt from consular legalization and authenticity verification requirements. Specifically, such documents may be exempt if the Drug Administration of Vietnam (DAV) is able to verify their authenticity directly through official electronic means, including written confirmation or email correspondence sent directly to the MOH by the competent foreign authority, or publicly accessible English-language databases maintained by recognized foreign regulatory authorities. In addition, the new circular permits the submission of electronic notarized copies of legal documents
Read More
July 24, 2026
As food innovation continues to accelerate, manufacturers are increasingly introducing ingredients derived from new sources, produced using novel technologies, or lacking a significant history of human consumption. While these innovations create new opportunities for the food industry, they also raise important questions regarding consumer safety. For this reason, many jurisdictions, including Thailand, the European Union, Australia and New Zealand, Canada, and Singapore, require a premarket safety assessment for novel food ingredients before they can be placed on the market. The objective of this assessment is to ensure that each ingredient is safe for its intended use and level of consumption, does not present toxicological, allergenic, microbiological, or nutritional concerns, and will not mislead consumers. Scientific authorities typically evaluate the ingredient’s identity, manufacturing process, composition, specifications, anticipated dietary exposure, toxicological information, nutritional impact, and history of use before determining whether it can be marketed. Against this background, the Thai Food and Drug Administration (FDA) recently took an important step toward improving regulatory transparency by publishing, for the first time, a consolidated public list of substances that have successfully completed the Thai FDA’s safety assessment process, including substances determined to be novel foods and those determined not to fall within the novel food category. The list identifies the approved substances, the corresponding manufacturers or importers, approval dates, and the approved conditions of use. Although the publication does not change the existing legal framework governing novel food approvals, it provides businesses with greater visibility into the Thai FDA’s regulatory precedents and the types of substances that have previously been accepted through the safety assessment process. The full announcement is available on the Thai FDA’s website. As the list is now publicly available, it also provides useful insight into the types of substances that have successfully completed the Thai FDA’s safety assessment process.
Read More
July 24, 2026
For businesses in Thailand’s regulated industries, the problem of “too many licenses” is one of the most familiar hurdles to getting a product to market. Take a simple example: importing the materials necessary to sell teriyaki chicken skewers. To legally do this, a business may need approvals from several different agencies—separate permits for the chicken (Department of Livestock Development), the dipping sauce (Thai FDA), the wooden skewers (Department of Forestry), and other ingredients, each under a different authority. This kind of overlap is often cited to argue for a “regulatory guillotine”—a systematic review to cut outdated or duplicative rules that slow investment and business activity. The Facilitation of Licensing and Public Service Consideration Act B.E. 2569 (2026) (Licensing Facilitation Act 2026) is Thailand’s most significant response yet to that concern. This article looks at the Facilitation Act 2026 through a life sciences and regulatory affairs lens—what it may mean for the manufacturers, importers, and distributors of food, drugs, medical devices, cosmetics, and similar products who routinely deal with several regulators to bring a single product to market. The Super License: One Approval Standing in for Many The reform with the clearest potential for regulated-product businesses is the law’s “super license” mechanism, referred to as a “main license” in the statute. Once a business obtains the main license for a regulated activity, it is automatically deemed to hold all related sublicenses issued by other agencies for that same activity, provided the activity has been designated as eligible in the Government Gazette. The Licensing Facilitation Act 2026 also creates a central application center, allowing applicants to submit a single application and pay all relevant fees at one point of contact, with the center routing the application to each agency through a shared information system. The potential benefits of this for businesses
Read More